Inventor · disambiguated record
Ulf Peters
Also filed as: PETERS ULF
9 granted patents·4 pending applications·145 citations·filing 1988–2024
90Inventor score
Top patents by PatentIndex Score
13 records- 0198US9810690B2Method for screening inhibitors of RasARAXES PHARMA LLC·Filed 2016·Granted Nov 7, 2017·41 cites·30 claims
- 0297US11603376B2Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2021·Granted Mar 14, 2023·6 cites·25 claims
- 0396US11891402B2Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2022·Granted Feb 6, 2024·3 cites·27 claims
- 0496US11718630B2Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2022·Granted Aug 8, 2023·4 cites·30 claims
- 0596US11008334B2Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2019·Granted May 18, 2021·21 cites·10 claims
- 0696US10023588B2Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2015·Granted Jul 17, 2018·30 cites·17 claims
- 0794US12116375B2Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2023·Granted Oct 15, 2024·1 cites·12 claims
- 0892US12365693B2Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2024·Granted Jul 22, 2025·0 cites·30 claims
- 0991US2025092061A1Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 1068US2019119295A1Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1164US2015087628A1Compositions and methods for treating cancerUNIV CALIFORNIA·Filed 2013·Application pending·0 cites
- 1259US2018246102A1Method for screening inhibitors of rasARAXES PHARMA LLC·Filed 2017·Application pending·0 cites
- 1347US4887611APlaster for conducting skin patch testsMIT BESCHRAENKTER HAFTUNG·Filed 1988·Granted Dec 19, 1989·39 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Ulf Peters files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →